4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-22-055136
EVP and COO sold 350 shares at $12.88 ($4,508)
- EVP and COO acquired 962 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Wolff Stefani · EVP and COO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-30 | Exercise or conversion : show line 1 in the form | +962 | 3,752 | D | ||
| 2022-10-31 | Sale : show line 2 in the form | −350 | $12.88 | $4,508 | 3,402 | D |
| Open-market sales · 350 sh · avg $12.88 · $4,508 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-10-30 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −962 | 12,506 | D |
Loading xslF345X03/doc4.xml…